Inovio to report second quarter 2025 financial results on august 12, 2025

Plymouth meeting, pa. , aug. 4, 2025 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancers, and infectious diseases, today announced that its second quarter 2025 financial results will be released after the market close on august 12, 2025.
INO Ratings Summary
INO Quant Ranking